Susan M. Flick

Statistics

Publications

Citations

419

H-Index

Active since

2006

Affiliations

University Hospitals Cleveland Medical Center(Current)

Case Western Reserve University

University School

Susan M. Flick is an author at University Hospitals Cleveland Medical Center specializing in pharmacology, cancer pharmacology, and toxicity management.

Publications per year

2006–2010

Publications

A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome

Colin Mooney, Govardhanan Nagaiah, Pingfu Fu et al. · Thyroid · 2009 · 182 citations

Medicine, Oncology, Pharmacology +12

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group

Joseph Gibbons, Merrill J. Egorin, Ramesh K. Ramanathan et al. · Journal of Clinical Oncology · 2008 · 135 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC)

Matthew M. Cooney, P. Savvides, Sanjiv S. Agarwala et al. · Journal of Clinical Oncology · 2006 · 54 citations

Medicine, Oncology, Pharmacology +9

Percutaneous Cryoablation of Renal Masses: Impact of Patient Selection and Treatment Parameters on Outcomes

Gino J. Vricella, John R. Haaga, Brittany L. Adler et al. · Urology · 2010 · 37 citations

Medicine, Nephrology, Surgery +14

A phase I study examining weekly dosing and pharmacokinetics (PK) of a novel spectrum selective kinase inhibitor, XL999, in patients (pts) with advanced solid malignancies (ASM)

James Cooper, Monica Mita, J. Curtright et al. · Journal of Clinical Oncology · 2006 · 11 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

1–5 of 5